Literature DB >> 24820087

Case report and cohort analysis of drug-induced liver injury associated with daptomycin.

Nicole Bohm1, Charles Makowski2, Mario Machado3, Adam Davie4, Nelson Seabrook4, Lee Wheless4, Benjamin Bevill5, Bradley Clark5, T Rogers Kyle6.   

Abstract

A patient receiving daptomycin developed asymptomatic transaminitis and hyperbilirubinemia without concurrent multiorgan dysfunction or elevation of his creatinine kinase level. After ruling out other etiologies, the liver injury was attributed to daptomycin and was subsequently resolved. A single-center retrospective cohort analysis of baseline and follow-up liver function panels (n = 614) from all admissions from 2008 to 2013 during which daptomycin was administered did not reveal any other cases of probable or definite drug-induced liver injury associated with daptomycin.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24820087      PMCID： PMC4136030          DOI： 10.1128/AAC.03157-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

Review 1.  Liver injury caused by drugs: an update.

Authors:  Guido Stirnimann; Kerstin Kessebohm; Bernhard Lauterburg
Journal:  Swiss Med Wkly       Date:  2010-09-24       Impact factor: 2.193

2.  Severe myopathy and possible hepatotoxicity related to daptomycin.

Authors:  Kelly Echevarria; Paromita Datta; Jose Cadena; James S Lewis
Journal:  J Antimicrob Chemother       Date:  2005-03-02       Impact factor: 5.790

3.  Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis.

Authors:  V A Maria; R M Victorino
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 5.  Daptomycin-induced acute renal and hepatic toxicity without rhabdomyolysis.

Authors:  George Abraham; Dmitry Finkelberg; Linda M Spooner
Journal:  Ann Pharmacother       Date:  2008-04-01       Impact factor: 3.154

Review 6.  Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.

Authors:  Rolf Teschke; Albrecht Wolff; Christian Frenzel; Alexander Schwarzenboeck; Johannes Schulze; Axel Eickhoff
Journal:  World J Hepatol       Date:  2014-01-27

7.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.

Authors:  G Danan; C Benichou
Journal:  J Clin Epidemiol       Date:  1993-11       Impact factor: 6.437
  7 in total
  5 in total

1.  Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system.

Authors:  Jiao-Jiao Chen; Xue-Chen Huo; Shao-Xia Wang; Fei Wang; Quan Zhao
Journal:  Int J Clin Pharm       Date:  2022-09-30

Review 2.  RUCAM in Drug and Herb Induced Liver Injury: The Update.

Authors:  Gaby Danan; Rolf Teschke
Journal:  Int J Mol Sci       Date:  2015-12-24       Impact factor: 5.923

Review 3.  Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019.

Authors:  Rolf Teschke
Journal:  Front Pharmacol       Date:  2019-07-23       Impact factor: 5.810

4.  High alanine aminotransaminase associated with daptomycin use in a premature infant.

Authors:  Suzan Suhail Asfour; Fahad Aljobair; Adli Abdelrahim; Mountasser Mohammad Al-Mouqdad
Journal:  J Mother Child       Date:  2021-10-11

5.  A case report and literature review of daptomycin-induced liver injury.

Authors:  Alena Janda; Mather R D Jogendra
Journal:  IDCases       Date:  2018-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.